| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6110651 | Pancreatology | 2016 | 6 Pages |
Abstract
The prevalence of pancreatic cancer in patients with new-onset type-2 diabetes is significantly higher than that in the general population and screening is beneficial for detecting PaC in this patient population. CA 19-9 and US is not reliable screening modality for pancreatic cancer screening in this population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Dóra Illés, Viktória Terzin, Gábor Holzinger, Klára Kosár, Richárd Róka, Gábor Zsóri, György Ábrahám, László Czakó,